These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 31410802)
1. In Vitro Assessment of the Hepatotoxicity Potential of Therapeutic Oligonucleotides. Sewing S; Minz T; Boess F Methods Mol Biol; 2019; 2036():249-259. PubMed ID: 31410802 [TBL] [Abstract][Full Text] [Related]
2. Establishment of a Predictive In Vitro Assay for Assessment of the Hepatotoxic Potential of Oligonucleotide Drugs. Sewing S; Boess F; Moisan A; Bertinetti-Lapatki C; Minz T; Hedtjaern M; Tessier Y; Schuler F; Singer T; Roth AB PLoS One; 2016; 11(7):e0159431. PubMed ID: 27442522 [TBL] [Abstract][Full Text] [Related]
3. In vitro evaluation of hepatotoxic drugs in human hepatocytes from multiple donors: Identification of P450 activity as a potential risk factor for drug-induced liver injuries. Utkarsh D; Loretz C; Li AP Chem Biol Interact; 2016 Aug; 255():12-22. PubMed ID: 26718876 [TBL] [Abstract][Full Text] [Related]
4. Human Upcyte Hepatocytes: Characterization of the Hepatic Phenotype and Evaluation for Acute and Long-Term Hepatotoxicity Routine Testing. Tolosa L; Gómez-Lechón MJ; López S; Guzmán C; Castell JV; Donato MT; Jover R Toxicol Sci; 2016 Jul; 152(1):214-29. PubMed ID: 27208088 [TBL] [Abstract][Full Text] [Related]
5. Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening. Gómez-Lechón MJ; Tolosa L Arch Toxicol; 2016 Sep; 90(9):2049-2061. PubMed ID: 27325232 [TBL] [Abstract][Full Text] [Related]
6. Chimeric Mice With Humanized Livers Demonstrate Human-Specific Hepatotoxicity Caused by a Therapeutic Antibody Against TRAIL-Receptor 2/Death Receptor 5. Nihira K; Nan-Ya KI; Kakuni M; Ono Y; Yoshikawa Y; Ota T; Hiura M; Yoshinari K Toxicol Sci; 2019 Jan; 167(1):190-201. PubMed ID: 30202993 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of multiple mechanism-based toxicity endpoints in primary cultured human hepatocytes for the identification of drugs with clinical hepatotoxicity: Results from 152 marketed drugs with known liver injury profiles. Zhang J; Doshi U; Suzuki A; Chang CW; Borlak J; Li AP; Tong W Chem Biol Interact; 2016 Aug; 255():3-11. PubMed ID: 26581450 [TBL] [Abstract][Full Text] [Related]
9. The use of hepatocytes to investigate drug toxicity. Gómez-Lechón MJ; Castell JV; Donato MT Methods Mol Biol; 2010; 640():389-415. PubMed ID: 20645064 [TBL] [Abstract][Full Text] [Related]
10. Integrative cross-omics analysis in primary mouse hepatocytes unravels mechanisms of cyclosporin A-induced hepatotoxicity. Van den Hof WF; Van Summeren A; Lommen A; Coonen ML; Brauers K; van Herwijnen M; Wodzig WK; Kleinjans JC Toxicology; 2014 Oct; 324():18-26. PubMed ID: 25047351 [TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation of potential hepatotoxicity induced by drugs. Gómez-Lechón MJ; Lahoz A; Gombau L; Castell JV; Donato MT Curr Pharm Des; 2010 Jun; 16(17):1963-77. PubMed ID: 20236064 [TBL] [Abstract][Full Text] [Related]
13. Prediction of Drug-Induced Liver Injury in Micropatterned Co-cultures Containing iPSC-Derived Human Hepatocytes. Ware BR; Berger DR; Khetani SR Toxicol Sci; 2015 Jun; 145(2):252-62. PubMed ID: 25716675 [TBL] [Abstract][Full Text] [Related]
14. Liver biomarker and in vitro assessment confirm the hepatic origin of aminotransferase elevations lacking histopathological correlate in beagle dogs treated with GABAA receptor antagonist NP260. Harrill AH; Eaddy JS; Rose K; Cullen JM; Ramanathan L; Wanaski S; Collins S; Ho Y; Watkins PB; Lecluyse EL Toxicol Appl Pharmacol; 2014 Jun; 277(2):131-7. PubMed ID: 24699182 [TBL] [Abstract][Full Text] [Related]
15. Sandwich-cultured hepatocytes: utility for in vitro exploration of hepatobiliary drug disposition and drug-induced hepatotoxicity. De Bruyn T; Chatterjee S; Fattah S; Keemink J; Nicolaï J; Augustijns P; Annaert P Expert Opin Drug Metab Toxicol; 2013 May; 9(5):589-616. PubMed ID: 23452081 [TBL] [Abstract][Full Text] [Related]
16. In vitro transcriptomic prediction of hepatotoxicity for early drug discovery. Cheng F; Theodorescu D; Schulman IG; Lee JK J Theor Biol; 2011 Dec; 290():27-36. PubMed ID: 21884709 [TBL] [Abstract][Full Text] [Related]
17. Characterization of rat or human hepatocytes cultured in microphysiological systems (MPS) to identify hepatotoxicity. Chang SY; Voellinger JL; Van Ness KP; Chapron B; Shaffer RM; Neumann T; White CC; Kavanagh TJ; Kelly EJ; Eaton DL Toxicol In Vitro; 2017 Apr; 40():170-183. PubMed ID: 28089783 [TBL] [Abstract][Full Text] [Related]
18. High-content screening technology for studying drug-induced hepatotoxicity in cell models. Tolosa L; Gómez-Lechón MJ; Donato MT Arch Toxicol; 2015 Jul; 89(7):1007-22. PubMed ID: 25787152 [TBL] [Abstract][Full Text] [Related]
19. Prediction of drug-induced immune-mediated hepatotoxicity using hepatocyte-like cells derived from human embryonic stem cells. Kim DE; Jang MJ; Kim YR; Lee JY; Cho EB; Kim E; Kim Y; Kim MY; Jeong WI; Kim S; Han YM; Lee SH Toxicology; 2017 Jul; 387():1-9. PubMed ID: 28645575 [TBL] [Abstract][Full Text] [Related]
20. Sensitivities of gel entrapped hepatocytes in hollow fibers to hepatotoxic drug. Meng Q; Zhang G; Shen C; Qiu H Toxicol Lett; 2006 Sep; 166(1):19-26. PubMed ID: 16814964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]